SYRS OTC
Syros Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +300.0%
YTD: +100.0%
1Y: +300.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±1453.3%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-90.5% YoY
$-98M
Net Income
-53.4% YoY
$-100M
Free Cash Flow
+18.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-777.0%
ROA-84.0%
ROIC960.6%
Valuation
P/E-0.0
P/B0.0
EV/EBITDA-0.9
Leverage
Debt/Equity-5.41
Current Ratio2.25
Interest Cov.-17.4x
Quality Scores
Piotroski F0/9
Altman Z-15.01
Beneish M0.00